Andrew Knasiak, Pharm D, MBA
About Andrew Knasiak, Pharm D, MBA
Andrew Knasiak, Pharm D, MBA, is an Associate Product Manager for Orencia Payer Marketing at Bristol Myers Squibb and a Staff Pharmacist at Ravitz Family Markets.
Company
Andrew Knasiak is currently employed at Bristol Myers Squibb in Princeton, New Jersey. He holds the position of Associate Product Manager Orencia Payer Marketing. In this role, he specifically focuses on payer marketing for Orencia, a medication used to treat rheumatoid arthritis.
Title
Andrew Knasiak serves as Associate Product Manager Orencia Payer Marketing at Bristol Myers Squibb. His responsibilities involve payer marketing strategies for Orencia, a medication aimed at treating rheumatoid arthritis. His title indicates his role in the development and execution of marketing plans targeting payers.
Education and Expertise
Andrew Knasiak studied at Rutgers University - Newark, where he earned a Master of Business Administration (MBA) in Pharmaceutical Marketing and Management from 2018 to 2020. He also holds a Doctor of Pharmacy (PharmD) degree from Rutgers University–New Brunswick, which he obtained from 2004 to 2010. His educational background combines pharmaceutical science and business, providing a comprehensive skill set for his role in pharmaceutical marketing.
Background
Andrew Knasiak has an extensive background in both pharmacy practice and pharmaceutical marketing. He initially worked as a Pharmacy Intern and later as a Staff Pharmacist at Walgreens from 2004 to 2014. Following this, he worked as a Staff Pharmacist at Ravitz Family Markets. Currently, he concurrently holds positions at both Bristol Myers Squibb and Ravitz Family Markets. He has participated in Bristol-Myers Squibb's Commercial Leadership Development Program, further sharpening his skills in pharmaceutical marketing.
Achievements
Andrew Knasiak's professional journey includes completing an MBA Summer Internship at Bristol-Myers Squibb in 2019. His comprehensive expertise is highlighted by his participation in the Commercial Leadership Development Program at Bristol-Myers Squibb. This hands-on experience, paired with his educational accomplishments, has equipped him with a robust understanding of both the clinical and business aspects of the pharmaceutical industry.